You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 6, June 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Factors related to corneal epithelial complications after closed vitrectomy in diabetics

G. N. Foulks, R. A. Thoft, H. D. Perry and F. I. Tolentino

In a series of 30 vitrectomy patients, postoperative corneal complications developed in 14 (47%). Thirteen (92%) of the 14 patients with complications were diabetic. Other factors that were positively correlated with the development of corneal complications included decreased corneal sensitivity, intraoperative lensectomy, and intraoperative epithelial debridement. The corneal complications involved the epithelium in 11 (78%) of the 14 complicated cases, with involvement of the endothelium (as manifested by stromal edema) in five (35%) cases. The diabetic human corneal epithelium contains considerable levels of sorbitol and fructose, which indicates the probable presence of the sorbitol pathway. As in the lens, this pathway may lead to osmotic changes that make the diabetic corneal epithelium more vulnerable to damage intraoperatively. Postoperatively, reepithelialization is delayed because of a probable failure of adhesion of cells to the underlying basement membrane.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Delayed Wound Closure and Phenotypic Changes in Corneal Epithelium of the Spontaneously Diabetic Goto-Kakizaki Rat
Wakuta et al.
IOVS 2007;48:590-596.
ABSTRACT | FULL TEXT  

A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients
Nakahara et al.
Br. J. Ophthalmol. 2005;89:266-268.
ABSTRACT | FULL TEXT  

Corneal Changes After Small-Incision Cataract Surgery in Patients With Diabetes Mellitus
Morikubo et al.
Arch Ophthalmol 2004;122:966-969.
ABSTRACT | FULL TEXT  

Noninvasive Assessment of Corneal Sensitivity in Young and Elderly Diabetic and Nondiabetic Subjects
Murphy et al.
IOVS 2004;45:1737-1742.
ABSTRACT | FULL TEXT  

Naltrexone, an Opioid Antagonist, Facilitates Reepithelialization of the Cornea in Diabetic Rat
Zagon et al.
Diabetes 2002;51:3055-3062.
ABSTRACT | FULL TEXT  

Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235
Fujishima and Tsubota
Br. J. Ophthalmol. 2002;86:860-863.
ABSTRACT | FULL TEXT  

Advanced Glycation End Products in Diabetic Corneas
Kaji et al.
IOVS 2000;41:362-368.
ABSTRACT | FULL TEXT  

Tear secretion and tear film function in insulin dependent diabetics
Goebbels
Br. J. Ophthalmol. 2000;84:19-21.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.